Literature DB >> 31211698

Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming.

Aimee Merino1, Bin Zhang1, Philip Dougherty1, Xianghua Luo2, Jinhua Wang3, Bruce R Blazar4, Jeffrey S Miller1, Frank Cichocki1.   

Abstract

A population of Natural Killer (NK) cells expressing the activating receptor NKG2C and the maturation marker CD57 expands in response to human cytomegalovirus (HCMV) infection. CD3-CD56dimCD57+NKG2C+ NK cells are similar to CD8+ memory T cells with rapid and robust effector function upon re-stimulation, persistence, and epigenetic remodeling of the IFNG locus. Chronic antigen stimulation drives CD8+ memory T cell proliferation while also inducing genome-wide epigenetic reprograming and dysfunction. We hypothesized that chronic stimulation could similarly induce epigenetic reprograming and dysfunction in NK cells. Here we show that chronic stimulation of adaptive NK cells through NKG2C using plate-bound agonistic antibodies in combination with IL-15 drove robust proliferation and activation of CD3-CD56dimCD57+NKG2C+ NK cells while simultaneously inducing high expression of the checkpoint inhibitory receptors LAG-3 and PD-1. Marked induction of checkpoint inhibitory receptors was also observed on the surface of adaptive NK cells co-cultured with HCMV-infected endothelial cells. Chronically stimulated adaptive NK cells were dysfunctional when challenged with tumor targets. These cells exhibited a pattern of epigenetic reprograming, with genome-wide alterations in DNA methylation. Our study has important implications for cancer immunotherapy and suggest that exhausted NK cells could be targeted with inhibitory checkpoint receptor blockade.

Entities:  

Keywords:  Immunology; NK cells

Year:  2019        PMID: 31211698      PMCID: PMC6715389          DOI: 10.1172/JCI125916

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  72 in total

1.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors.

Authors:  Hisashi Arase; Edward S Mocarski; Ann E Campbell; Ann B Hill; Lewis L Lanier
Journal:  Science       Date:  2002-04-11       Impact factor: 47.728

4.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

5.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

6.  NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway.

Authors:  Daniel D Billadeau; Jadee L Upshaw; Renee A Schoon; Christopher J Dick; Paul J Leibson
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

7.  Imprint of human cytomegalovirus infection on the NK cell receptor repertoire.

Authors:  Mónica Gumá; Ana Angulo; Carlos Vilches; Natalia Gómez-Lozano; Núria Malats; Miguel López-Botet
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

8.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor.

Authors:  Hamish R C Smith; Jonathan W Heusel; Indira K Mehta; Sungjin Kim; Brigitte G Dorner; Olga V Naidenko; Koho Iizuka; Hiroshi Furukawa; Diana L Beckman; Jeanette T Pingel; Anthony A Scalzo; Daved H Fremont; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

9.  Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.

Authors:  D Pende; S Parolini; A Pessino; S Sivori; R Augugliaro; L Morelli; E Marcenaro; L Accame; A Malaspina; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

10.  TOX provides a link between calcineurin activation and CD8 lineage commitment.

Authors:  Parinaz Aliahmad; Emmett O'Flaherty; Peggy Han; Olivia D Goularte; Beverley Wilkinson; Masanobu Satake; Jeffery D Molkentin; Jonathan Kaye
Journal:  J Exp Med       Date:  2004-04-12       Impact factor: 14.307

View more
  53 in total

Review 1.  NK Cells and ILC1s in Cancer Biology.

Authors:  Anna Sliz; Wayne M Yokoyama
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Epigenetic regulation of natural killer cell memory.

Authors:  Colleen M Lau; Gabriela M Wiedemann; Joseph C Sun
Journal:  Immunol Rev       Date:  2021-12-14       Impact factor: 12.988

3.  Natural killer cell detection, quantification, and subpopulation identification on paper microfluidic cell chromatography using smartphone-based machine learning classification.

Authors:  Ryan Zenhausern; Alexander S Day; Babak Safavinia; Seungmin Han; Paige E Rudy; Young-Wook Won; Jeong-Yeol Yoon
Journal:  Biosens Bioelectron       Date:  2021-12-24       Impact factor: 10.618

4.  Minimal PD-1 expression in mouse and human NK cells under diverse conditions.

Authors:  Sean J Judge; Cordelia Dunai; Ethan G Aguilar; Sarah C Vick; Ian R Sturgill; Lam T Khuat; Kevin M Stoffel; Jonathan Van Dyke; Dan L Longo; Morgan A Darrow; Stephen K Anderson; Bruce R Blazar; Arta M Monjazeb; Jonathan S Serody; Robert J Canter; William J Murphy
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

5.  The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.

Authors:  Tim D Holmes; Ram Vinay Pandey; Eric Y Helm; Heinrich Schlums; Hongya Han; Tessa M Campbell; Theodore T Drashansky; Samuel Chiang; Cheng-Ying Wu; Christine Tao; Moneef Shoukier; Eva Tolosa; Sandra Von Hardenberg; Miao Sun; Christian Klemann; Rebecca A Marsh; Colleen M Lau; Yin Lin; Joseph C Sun; Robert Månsson; Frank Cichocki; Dorina Avram; Yenan T Bryceson
Journal:  Sci Immunol       Date:  2021-03-12

6.  Low-density PD-1 expression on resting human natural killer cells is functional and upregulated after transplantation.

Authors:  Zachary Davis; Martin Felices; Todd Lenvik; Sujan Badal; Joshua T Walker; Peter Hinderlie; James L Riley; Daniel A Vallera; Bruce R Blazar; Jeffrey S Miller
Journal:  Blood Adv       Date:  2021-02-23

7.  LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia.

Authors:  Christian Sordo-Bahamonde; Seila Lorenzo-Herrero; Ana P González-Rodríguez; Ángel R Payer; Esther González-García; Alejandro López-Soto; Segundo Gonzalez
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 8.  Unraveling exhaustion in adaptive and conventional NK cells.

Authors:  Aimee M Merino; Hansol Kim; Jeffrey S Miller; Frank Cichocki
Journal:  J Leukoc Biol       Date:  2020-07-29       Impact factor: 4.962

Review 9.  Natural killer cells in antiviral immunity.

Authors:  Niklas K Björkström; Benedikt Strunz; Hans-Gustaf Ljunggren
Journal:  Nat Rev Immunol       Date:  2021-06-11       Impact factor: 53.106

10.  Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.

Authors:  Emily Chiu; Martin Felices; Frank Cichocki; Zachary Davis; Hongbo Wang; Katie Tuninga; Daniel A Vallera; Tom Lee; Ryan Bjordahl; Karl Johan Malmberg; Bahram Valamehr; Jeffrey S Miller
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.